They can enhance anti-tumor immune response by producing pro-inflammatory cytokines (e.g., interleukin-1 (IL-1), IL-6, IL-12, IL-23, CXCL-10 and TNF-α), which help to recruit and activate immune cells to target the tumor. This evidence concerns the gene CXCL10 and neoplasm.